Targeting androgen receptor in estrogen receptor-negative breast cancer
about
Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancerMacrophages contribute to the cyclic activation of adult hair follicle stem cellsRole of the androgen receptor in breast cancer and preclinical analysis of enzalutamideProlactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancerPhase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast CancerPioneer transcription factors: establishing competence for gene expressionTamoxifen Resistance: Emerging Molecular TargetsCancer Hallmarks, Biomarkers and Breast Cancer Molecular SubtypesMechanisms of oestrogen receptor (ER) gene regulation in breast cancerCooperating transcription factors mediate the function of estrogen receptorTargeting the androgen receptor in prostate and breast cancer: several new agents in developmentRegulation of mammary epithelial cell homeostasis by lncRNAsRunx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferationSignificance of PELP1 in ER-negative breast cancer metastasisA Methodology for Cancer Therapeutics by Systems Pharmacology-Based Analysis: A Case Study on Breast Cancer-Related Traditional Chinese MedicinesMolecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapyCistrome plasticity and mechanisms of cistrome reprogrammingReduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.Wnt-responsive cancer stem cells are located close to distorted blood vessels and not in hypoxic regions in a p53-null mouse model of human breast cancer.The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling.Androgen Receptor as a Potential Target for Treatment of Breast Cancer.Importance of Breast Cancer Subtype in the Development of Androgen Receptor Directed Therapy.Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events.Wnt signaling in cancerBioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modificationsAndrogen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associationsEstrogen receptor alpha and androgen receptor are commonly expressed in well-differentiated liposarcoma.A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland.Coagulation factor VII is regulated by androgen receptor in breast cancer.Mammary cells with active Wnt signaling resist ErbB2-induced tumorigenesisAndrogen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.AR collaborates with ERα in aromatase inhibitor-resistant breast cancer.A molecular analysis provides novel insights into androgen receptor signalling in breast cancer.FOXA1: master of steroid receptor function in cancer.Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients.Recent progress in targeting cancer.Bioinformatics Knowledge Map for Analysis of Beta-Catenin Function in Cancer.New insights into the role of androgen and oestrogen receptors in molecular apocrine breast tumours
P2860
Q21132473-E5657EBA-FE77-4B7E-A1AE-06B9C78AA73BQ21145702-80C6B26F-815A-41FB-9C76-B4FDFADF7B55Q21195191-BA8EF5D5-48C1-4D78-9923-460133854682Q21195199-1290109D-CDBC-42A6-BDD7-2E005D566484Q24563045-9C5A6F91-EF14-4E54-818C-6071D9546B9FQ24625373-A54ABC08-6630-4849-8D69-2D2B4C49F815Q26739969-086224CE-2C75-4E6B-A6A3-9A2D905E6F5CQ26743510-4C7F9EB2-AE2A-4CAD-9FFF-EE1EE79BA2B0Q26765380-805D0D6A-AB11-46AD-9FE4-72A83FD043A8Q26996464-A3C9BEA7-47FD-401C-9F7A-A0E9857860C4Q27009424-C300294F-44F7-4706-9DC1-EC32C3D5A3B2Q27011533-3621DCC2-C815-4D95-AC6E-817133E364CFQ28244711-A0EBF63F-F469-45C7-88B3-C656FD5971ABQ28253038-D730C1E2-AAAC-474C-8E20-BF57CF16F6A6Q28468359-DFE3720F-E0BB-4C09-9740-E3C85C50A6C9Q28535227-3B93BF23-1669-44F8-B4E3-F00D8D622D4DQ28727255-6AA20357-5745-4771-AB6F-D0C140743965Q30419961-69E465C8-9E19-47E4-8CFC-82DE2485C2A7Q30581875-AB25B2AF-1BC5-42CC-958B-D5F5DAFF72E2Q30978083-15E94C21-614E-45E5-9B4D-D36145695E3CQ33612132-B6C0F39B-5CE2-4671-91E9-EAAA38A8938FQ33625672-E0461CD4-5DBB-4665-8218-94BF8A0FF151Q33632582-354E9F8F-1D60-47F1-AE51-8CB1BBCB3B59Q33728381-097F8762-59BD-4CAD-BF5A-BF8C9D707936Q34218734-225FD2B5-0B17-46EB-90E2-CCA5458426E0Q34262857-03A14333-800B-43EB-B8B1-7C29DC6A4402Q34291226-AB1DE77D-A2B6-4072-AF06-197166FDB782Q34309894-DBBF2108-375F-46D0-83CE-AD51AF3113EBQ34404655-7ECE90CE-F655-4D5F-BAA3-8704BD817611Q34550256-F893DA80-255D-4061-964B-406886A61095Q34995790-7BF974A6-AD8E-494F-9C06-9BA3CC51EC9FQ35050344-6A08143C-117D-4E77-9951-9D03A8A81CDEQ35088745-B5BBE497-2A12-4E3A-911C-C2BF6DA977D4Q35112392-42BF1CA9-9071-4DAB-AA52-C38FBBA71836Q35189443-519FBABD-D546-4D2C-A6DD-B96CFF971C63Q35532767-0C8A878F-23BB-42E1-A729-F8D460D65E87Q35683329-A986EE83-8599-460E-AEE9-2079B5D097E1Q35740782-E3F5C155-921A-4AA3-A789-5D3DDF5D6663Q35824062-DCE0C6AF-4AEE-4391-9B0F-A6E83ED8C875Q35889554-D6CCAA19-28A1-4FBD-9C2A-5873ADE2165F
P2860
Targeting androgen receptor in estrogen receptor-negative breast cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeting androgen receptor in estrogen receptor-negative breast cancer
@ast
Targeting androgen receptor in estrogen receptor-negative breast cancer
@en
Targeting androgen receptor in estrogen receptor-negative breast cancer
@en-gb
Targeting androgen receptor in estrogen receptor-negative breast cancer
@nl
type
label
Targeting androgen receptor in estrogen receptor-negative breast cancer
@ast
Targeting androgen receptor in estrogen receptor-negative breast cancer
@en
Targeting androgen receptor in estrogen receptor-negative breast cancer
@en-gb
Targeting androgen receptor in estrogen receptor-negative breast cancer
@nl
prefLabel
Targeting androgen receptor in estrogen receptor-negative breast cancer
@ast
Targeting androgen receptor in estrogen receptor-negative breast cancer
@en
Targeting androgen receptor in estrogen receptor-negative breast cancer
@en-gb
Targeting androgen receptor in estrogen receptor-negative breast cancer
@nl
P2093
P2860
P3181
P1433
P1476
Targeting androgen receptor in estrogen receptor-negative breast cancer
@en
P2093
David L Rimm
Hallie Wimberly
Shannon T Bailey
X Shirley Liu
Yiwen Chen
Yuuki Imai
P2860
P304
P3181
P356
10.1016/J.CCR.2011.05.026
P407
P577
2011-07-12T00:00:00Z